Lung Cancer

Aims & Scope

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.4
2024	4.50

SJR (SCImago Journal Rank)

Year	Value
2024	1.752

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	154

Journal Rank

Year	Value
2024	1814

Journal Citation Indicator

Year	Value
2024	3233

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

  Citation: 702

  Authors: Stefan, Sabine, Mirjam, Lukas, Diana, Wolfram, Arnoud J., Martin

• Metastatic sites and survival in lung cancer

  Citation: 663

  Authors: M., A., M., H., K., J., K.

• Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument

  Citation: 624

  Authors: David F., Amy E., Stephen R., David S., Edward, Philip

• Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

  Citation: 590

  Authors: M., J.B.

• Tobacco smoking and cancer: a brief review of recent epidemiological evidence

  Citation: 544

  Authors: A.J., M.B., K.

• Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

  Citation: 407

  Authors: Deepa, Norihiro, Paul A., Erik, Anand, Scott R., Erik J., Eric T., Suzanne E., Mark S., Daniel B.

• EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291

  Citation: 391

  Authors: Kenneth S., Roz, T. Hedley, Simon, Suzanne, Helen, Tracey, Mireille, J. Carl

• Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

  Citation: 388

  Authors: Stephen J., Shawn, Charu, Joshua M., Evan W., Tracey L., John A., Christine A., Peter E., Jeffrey C., Susan, Victoria E., Elizabeth, Beth, Faith, Gloria, Roger B., Anil, Corey J.

• Complete resection in lung cancer surgery: proposed definition

  Citation: 376

  Authors: Ramón, Christian, Peter

• Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis

  Citation: 373

  Authors: Sadik A.

---